Skip to content

To evaluate the efficacy of saddyo virechana and virechana karma in Amlapitta

Comparative clinical evaluation of Saddyo-virechana and virechana karma by Aragwadhadi Avleha in Amlapitta (GERD) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094591
Enrollment
40
Registered
2025-09-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K210- Gastro-esophageal reflux disease with esophagitis

Interventions

None listed

Sponsors

Dr Mansi Kukreti
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients presenting with Samanya lakshanas of Amlapitta. 2.Patients who fit for Virechana karma. 3.Patients will be selected irrespective of sex, caste, socio economic status.

Exclusion criteria

Exclusion criteria: 1.Patients with uncontrolled diabetes,HTN, systemic disorders and endocrine disorders, diagnosed peptic ulcer disease and any other malignancy. 2.Pregnant women, lactating mothers and menstruating females. 3.Patients with communicable diseases and autoimmune diseases. 4.Duration of illness more than 5 years.

Design outcomes

Primary

MeasureTime frame
Relief in Avipaka, Klama, Utklesha, Hrit-kantha daha, tikta-Amla-udgaar and chest pain.Timepoint: IN GROUP A- 1 week IN GROUP B- 4 weeks

Secondary

MeasureTime frame
relief in sign, symptoms Timepoint: Group A- After 2 weeks & 4 weeks of procedure Group B - After 2 weeks & 4 weeks of procedure.

Countries

India

Contacts

Public ContactDr Arvind Gupta

Himalayiya Ayurvedic PG Medical College and Hospital

arvindguptapk@gmail.com7895624474

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026